Author

K. Attwood

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:metabolomics· 1

Frequent Co-Authors

F. Ito· 2 shared T. Hoki· 2 shared T. Oba· 2 shared T. Yamauchi· 2 shared A. Woloszynska· 1 shared B. H. Segal· 1 shared C. Morrison· 1 shared C. Xuefang· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

F. Ito

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Racial differences in androgen metabolism and receptor signaling in prostate cancer

S. Ramakrishnan, E. C. Gomez, K. Attwood, R. A. Kittles, J. Wang, S. R. Rosario, D. J. Smiraglia, G. Azabdaftari, J. L. Mohler, W. J. Huss, A. Woloszynska

This study identifies racial differences in androgen metabolism and receptor signaling in prostate cancer, showing African American men use an alternative pathway for DHT biosynthesis associated with disease progression.

bioRxiv · Mar 31, 2021 · PreprintCancer Biology

CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells in mice

T. Yamauchi, T. Hoki, T. Oba, K. Attwood, C. Xuefang, F. Ito

This study shows that CD40 and CD80/86 signaling in cDC1s enhances neoantigen vaccine efficacy and generates CX3CR1+ CD8+ T cells in mice.

bioRxiv · Jun 15, 2020Immunology

A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors

T. Yamauchi, T. Hoki, T. Oba, V. Jain, H. Chen, K. Attwood, S. Battaglia, S. George, G. Chatta, I. Puzanov, C. Morrison, K. Odunsi, B. H. Segal, G. K. Dy, M. S. Ernstoff, F. Ito

The paper identifies CX3CR1 expression on circulating CD8+ T cells as a biomarker predicting response to immune checkpoint inhibitor therapy in NSCLC patients.

bioRxiv · Jun 13, 2020Immunology